WO2004043435A3 - Systemic delivery of antiviral agents - Google Patents
Systemic delivery of antiviral agents Download PDFInfo
- Publication number
- WO2004043435A3 WO2004043435A3 PCT/US2003/036637 US0336637W WO2004043435A3 WO 2004043435 A3 WO2004043435 A3 WO 2004043435A3 US 0336637 W US0336637 W US 0336637W WO 2004043435 A3 WO2004043435 A3 WO 2004043435A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agent
- risk
- treating
- reducing
- antiviral agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003287666A AU2003287666A1 (en) | 2002-11-13 | 2003-11-13 | Systemic delivery of antiviral agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42594302P | 2002-11-13 | 2002-11-13 | |
US60/425,943 | 2002-11-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004043435A2 WO2004043435A2 (en) | 2004-05-27 |
WO2004043435A3 true WO2004043435A3 (en) | 2004-07-08 |
Family
ID=32313080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/036637 WO2004043435A2 (en) | 2002-11-13 | 2003-11-13 | Systemic delivery of antiviral agents |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003287666A1 (en) |
WO (1) | WO2004043435A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
DK2155169T3 (en) | 2007-06-08 | 2016-06-13 | Boehringer Ingelheim Int | Formulation of nevirapine extended release |
AU2010249683B2 (en) * | 2009-05-18 | 2015-06-25 | Dose Medical Corporation | Drug eluting ocular implant |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
EP2515864A4 (en) * | 2009-12-23 | 2013-09-11 | Psivida Inc | Sustained release delivery devices |
AR088463A1 (en) | 2011-10-21 | 2014-06-11 | Abbvie Inc | METHODS FOR HCV TREATMENT |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
TWI532485B (en) | 2011-10-21 | 2016-05-11 | 艾伯維有限公司 | Methods for treating hcv |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
KR20170016884A (en) * | 2014-05-30 | 2017-02-14 | 텍스타일-베이스드 딜리버리, 인코포레이티드 | Drug delivery systems and related methods of use |
WO2016069898A1 (en) | 2014-10-30 | 2016-05-06 | Textile-Based Delivery, Inc. | Delivery systems |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
EP3442479A1 (en) | 2016-04-20 | 2019-02-20 | Harold Alexander Heitzmann | Bioresorbable ocular drug delivery device |
EP3448392A4 (en) | 2016-04-28 | 2020-01-15 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
US6039975A (en) * | 1995-10-17 | 2000-03-21 | Hoffman-La Roche Inc. | Colon targeted delivery system |
-
2003
- 2003-11-13 WO PCT/US2003/036637 patent/WO2004043435A2/en not_active Application Discontinuation
- 2003-11-13 AU AU2003287666A patent/AU2003287666A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US6039975A (en) * | 1995-10-17 | 2000-03-21 | Hoffman-La Roche Inc. | Colon targeted delivery system |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
Also Published As
Publication number | Publication date |
---|---|
WO2004043435A2 (en) | 2004-05-27 |
AU2003287666A1 (en) | 2004-06-03 |
AU2003287666A8 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004043435A3 (en) | Systemic delivery of antiviral agents | |
WO2001080825A3 (en) | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof | |
WO2004091444A3 (en) | Implantable medical device comprising therapeutic agents with different diffusion rates | |
NO20034684D0 (en) | Device for administering funds through the stratum corcum | |
WO2004010975A3 (en) | Controlled drug delivery | |
WO2003077972A8 (en) | Implantable drug delivery system | |
NO962833L (en) | Transdermal preparation comprising polyvinylpyrrolidine | |
WO2004062600A3 (en) | Antiviral patch | |
WO2008086375A3 (en) | Non-invasive vascular treatment systems, devices, and methods of using the same | |
NO20051964D0 (en) | Therapeutic preparations for drug delivery to and through the epithelium | |
WO2006036982A3 (en) | Drug delivery coating for use with a stent | |
DE60136910D1 (en) | DEVICE WITH ENERGY CONVERSION DEVICES FOR IMPOTENA TREATMENT | |
WO2005079387A3 (en) | Implantable drug delivery device including wire filaments | |
WO2003028660A3 (en) | Drug delivery devices and methods | |
WO2000038714A8 (en) | The prevention and treatment of retinal ischemia and edema | |
DK1133269T3 (en) | Controlled delivery device for administration of therapeutics in the inner ear | |
WO2001043749A3 (en) | Pharmaceutical implant containing immediate-release and sustained-release components and method of administration | |
WO2007030478A3 (en) | Implantable device for therapeutic treatment within a body lumen | |
CA2401000A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
AU3401093A (en) | Therapeutic agent for threatened abortion | |
CY1106702T1 (en) | USE OF A COMBINATION OF A PURINE AND A NITROGEN MONOXIDE DONATOR FOR THE PREVENTION OR TREATMENT OF BENEFITS OF BENEFITS | |
WO2001041771A3 (en) | Transdermal system containing acetylsalicylic acid for treatment of migraine | |
AR109456A2 (en) | USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY | |
WO2002007760A3 (en) | Therapeutic agent against aids comprising anti hiv goat antibody | |
James | New double vs. triple antiviral combination study, CD4 200-500, no prior treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |